AU2013343685B2 - Collagen hydrolyzate and use thereof - Google Patents

Collagen hydrolyzate and use thereof Download PDF

Info

Publication number
AU2013343685B2
AU2013343685B2 AU2013343685A AU2013343685A AU2013343685B2 AU 2013343685 B2 AU2013343685 B2 AU 2013343685B2 AU 2013343685 A AU2013343685 A AU 2013343685A AU 2013343685 A AU2013343685 A AU 2013343685A AU 2013343685 B2 AU2013343685 B2 AU 2013343685B2
Authority
AU
Australia
Prior art keywords
collagen hydrolysate
collagen
weight
gelatin
nutritional supplement
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
AU2013343685A
Other languages
English (en)
Other versions
AU2013343685A1 (en
AU2013343685A8 (en
Inventor
Hans-Ulrich Frech
Monika Giesen-Wiese
Stephan Hausmanns
Steffen Oesser
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Gelita AG
Original Assignee
Gelita AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=49578271&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AU2013343685(B2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Gelita AG filed Critical Gelita AG
Publication of AU2013343685A1 publication Critical patent/AU2013343685A1/en
Publication of AU2013343685A8 publication Critical patent/AU2013343685A8/en
Application granted granted Critical
Publication of AU2013343685B2 publication Critical patent/AU2013343685B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/01—Hydrolysed proteins; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
    • A23J3/00—Working-up of proteins for foodstuffs
    • A23J3/30—Working-up of proteins for foodstuffs by hydrolysis
    • A23J3/32—Working-up of proteins for foodstuffs by hydrolysis using chemical agents
    • A23J3/34—Working-up of proteins for foodstuffs by hydrolysis using chemical agents using enzymes
    • A23J3/341—Working-up of proteins for foodstuffs by hydrolysis using chemical agents using enzymes of animal proteins
    • A23J3/342—Working-up of proteins for foodstuffs by hydrolysis using chemical agents using enzymes of animal proteins of collagen; of gelatin
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/18—Peptides; Protein hydrolysates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/32—Bones; Osteocytes; Osteoblasts; Tendons; Tenocytes; Teeth; Odontoblasts; Cartilage; Chondrocytes; Synovial membrane
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/01—Hydrolysed proteins; Derivatives thereof
    • A61K38/012—Hydrolysed proteins; Derivatives thereof from animals
    • A61K38/014—Hydrolysed proteins; Derivatives thereof from animals from connective tissue peptides, e.g. gelatin, collagen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Rheumatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Nutrition Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Virology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Toxicology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
AU2013343685A 2012-11-06 2013-11-04 Collagen hydrolyzate and use thereof Active AU2013343685B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE102012110612.6A DE102012110612A1 (de) 2012-11-06 2012-11-06 Kollagenhydrolysat und dessen Verwendung
DE102012110612.6 2012-11-06
PCT/EP2013/072894 WO2014072235A1 (de) 2012-11-06 2013-11-04 Kollagenhydrolysat und dessen verwendung

Publications (3)

Publication Number Publication Date
AU2013343685A1 AU2013343685A1 (en) 2015-05-21
AU2013343685A8 AU2013343685A8 (en) 2015-07-02
AU2013343685B2 true AU2013343685B2 (en) 2018-03-29

Family

ID=49578271

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2013343685A Active AU2013343685B2 (en) 2012-11-06 2013-11-04 Collagen hydrolyzate and use thereof

Country Status (13)

Country Link
US (1) US10364283B2 (https=)
EP (1) EP2916855B1 (https=)
JP (1) JP6272891B2 (https=)
CN (1) CN104768566B (https=)
AU (1) AU2013343685B2 (https=)
BR (1) BR112015009473B1 (https=)
CL (1) CL2015001159A1 (https=)
DE (1) DE102012110612A1 (https=)
ES (1) ES2587928T3 (https=)
MX (1) MX2015005649A (https=)
PL (1) PL2916855T3 (https=)
RU (1) RU2671401C2 (https=)
WO (1) WO2014072235A1 (https=)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11998654B2 (en) 2018-07-12 2024-06-04 Bard Shannon Limited Securing implants and medical devices

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102013104897A1 (de) 2013-05-13 2014-11-13 Gelita Ag Wirkstoff zur Behandlung von Sarkopenie
DE102014117036A1 (de) 2014-11-20 2016-05-25 RenaCare NEPHROMED GmbH Zusammensetzung zur Eiweißsubstitution
DE202014105602U1 (de) 2014-11-20 2015-11-23 RenaCare NEPHROMED GmbH Zusammensetzung zur Eiweißsubstitution
RU2659383C2 (ru) * 2015-10-20 2018-06-29 федеральное государственное автономное образовательное учреждение высшего образования "Казанский (Приволжский) федеральный университет" (ФГАОУ ВО КФУ) Биоактивный гидрогель для регенерации кожи
DE102015121923A1 (de) * 2015-12-16 2017-06-22 Gelita Ag Gießmasse und Verfahren für die Herstellung von Gelatineprodukten
GR1009140B (el) * 2016-01-12 2017-10-20 Σωτηρης Γεωργιου Χορτομαρης Συμπληρωμα διατροφης με χοιρινο και βοϊο κολλαγονο υδρολυμενο και ζελατινη
EP3411016B1 (en) 2016-02-03 2024-09-11 Fresenius Kabi Deutschland GmbH High caloric, high protein nutritional formula
NL2017219B1 (en) * 2016-07-22 2018-01-30 Rousselot B V Low cross-linking gelatine
US11110147B2 (en) * 2017-03-15 2021-09-07 Rousselot B.V Collagen hydrolysates as a beneficial prebiotic and their effect on joint inflammation and osteoarthritis
CN107083415A (zh) * 2017-05-27 2017-08-22 四川汇宇生物技术有限公司 一种明胶的生产方法
DE102018120420A1 (de) * 2018-08-22 2020-02-27 Gelita Ag Proteinriegel
DE102019202606A1 (de) * 2018-11-06 2020-05-07 Gelita Ag Rekombinante Herstellung eines Kollagenpeptidpräparates und dessen Verwendung
DE102019207859A1 (de) 2018-12-21 2020-06-25 Gelita Ag Synthetische und rekombinant hergestellte Kollagenpeptide mit biologischer Wirksamkeit
DE102020210725A1 (de) 2019-10-31 2021-05-06 Gelita Ag Ernährungsphysiologisch optimiertes Kollagenpeptid
DE102019130196A1 (de) * 2019-11-08 2021-05-12 Gelita Ag Verfahren zur Herstellung von Kollagenpeptiden aus Knochen, und hergestellte Kollagenpeptide
DE102019130197A1 (de) * 2019-11-08 2021-05-12 Gelita Ag Verfahren zur Herstellung von Knochengelatine, und hergestellte Knochengelatine
US20210145764A1 (en) * 2019-11-15 2021-05-20 Brigham Young University Compositions of cannabidiol (cbd), and/or polyphenols, and methods for the prevention and/or treatment of skin, muscle, nerve and inflammatory disorders, and biological factors and functions in mammals
CA3164511A1 (en) 2020-01-13 2021-07-22 Chathurada GAJADEERA Turkey collagen hydrolysates and methods of making
DE102020126594A1 (de) * 2020-10-09 2022-04-14 Gelita Ag Kollagenhydrolysat als Wirkstoff zum Verzögern der Alterung
JP7631623B2 (ja) * 2022-08-31 2025-02-18 ルースロ ビーヴイ 集中治療後症候群（ｐｉｃｓ）の予防及び／又は治療に使用するためのコラーゲン加水分解物
DE202023107635U1 (de) 2023-12-22 2024-02-08 RenaCare NEPHROMED GmbH Zusammensetzung zur Eiweißsubstitution
CN120060939B (zh) * 2025-01-26 2025-12-02 大连理工大学 一种纳米孪晶铜电镀添加剂及电镀液

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5120761A (en) * 1988-10-14 1992-06-09 Finnan Jeffrey L Method of making a free-flowing spray dried edible powder comprising an oil

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2859343B2 (ja) * 1988-10-14 1999-02-17 ビーエーエスエフ、コーポレーション 油を含んで成る自由流動性噴霧乾燥食用粉末の製造法
AU699192B2 (en) * 1993-08-13 1998-11-26 Bayer Corporation Hydrolyzed gelatin as a flavor enhancer in a chewable tablet
FR2720067B1 (fr) 1994-05-17 1996-08-02 Dielen Lab Hydrolysat de protéines d'animaux marins, procédé d'obtention et applications.
EP0777491B1 (de) 1994-08-23 2004-11-17 Deutsche Gelatine-Fabriken Stoess AG Verwendung von geschmacksneutralem, hydrolysiertem kollagen und mittel enthaltend dasselbe
JP4609807B2 (ja) 1996-03-28 2011-01-12 雪印乳業株式会社 骨強化用医薬、飲食品及び飼料
JPH1112192A (ja) * 1997-06-18 1999-01-19 Zenyaku Kogyo Kk 骨粗鬆症予防・治療剤
US20020025921A1 (en) * 1999-07-26 2002-02-28 Petito George D. Composition and method for growing, protecting, and healing tissues and cells
GB0031065D0 (en) * 2000-12-20 2001-01-31 Univ Cardiff Preservation of cells
GB2418431A (en) * 2004-09-27 2006-03-29 Multigerm Uk Entpr Ltd Metabolically active micro organisms and methods for their production
US7485323B2 (en) * 2005-05-31 2009-02-03 Gelita Ag Process for making a low molecular weight gelatine hydrolysate and gelatine hydrolysate compositions
WO2007044945A2 (en) 2005-10-13 2007-04-19 Gu, Jennifer, L. Mineral collagen chelates and methods of making and using same
EP2088157A4 (en) 2006-11-15 2009-12-30 Meiji Seika Kaisha COLLAGEN PEPTIDE COMPOSITION AND FOOD OR BEVERAGE CONTAINING THEREOF
US20120142598A1 (en) * 2006-12-18 2012-06-07 Zeev Pam Edible compositions for preventing hair loss
JP2008247809A (ja) 2007-03-30 2008-10-16 Yaizu Suisankagaku Industry Co Ltd コラーゲン錠剤
FR2927336B1 (fr) * 2008-02-12 2010-05-21 Cie Des Peches Saint Malo Sant Hydrolysat de proteines de poissons presentant une activite de stimulation et de maintien du capital osseux, compositions nutraceutiques et pharmacologiques comprenant un tel hydrolysat et procede d'obtention
DE102009030351A1 (de) 2009-06-22 2010-12-23 Gelita Ag Zusammensetzung zur Behandlung von degenerativen Gelenkerkrankungen
CN102094056B (zh) 2009-12-14 2013-04-03 包头东宝生物技术股份有限公司 可溶性胶原蛋白的制备方法
JP5370225B2 (ja) * 2010-03-18 2013-12-18 株式会社デンソーウェーブ ロボットのアーム連結装置
DE102010060564A1 (de) 2010-11-15 2012-05-16 Gelita Ag Verwendung von Kollagenhydrolysat zur Verbesserung der Gesundheit der menschlichen Haut, Haare und/oder Nägel
DE102011000997A1 (de) * 2011-03-01 2012-09-06 Gelita Ag Zusammensetzung für Ernährungszwecke
US8603183B2 (en) * 2011-06-22 2013-12-10 Shinn Jyh Ding Bilayered bone graft device

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5120761A (en) * 1988-10-14 1992-06-09 Finnan Jeffrey L Method of making a free-flowing spray dried edible powder comprising an oil

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11998654B2 (en) 2018-07-12 2024-06-04 Bard Shannon Limited Securing implants and medical devices

Also Published As

Publication number Publication date
EP2916855A1 (de) 2015-09-16
EP2916855B1 (de) 2016-07-27
AU2013343685A1 (en) 2015-05-21
DE102012110612A1 (de) 2014-05-08
US20150232534A1 (en) 2015-08-20
CN104768566A (zh) 2015-07-08
AU2013343685A8 (en) 2015-07-02
JP2015534812A (ja) 2015-12-07
CN104768566B (zh) 2018-06-29
US10364283B2 (en) 2019-07-30
BR112015009473A2 (pt) 2017-07-04
PL2916855T3 (pl) 2017-08-31
RU2015121573A (ru) 2016-12-27
BR112015009473B1 (pt) 2022-10-04
WO2014072235A1 (de) 2014-05-15
JP6272891B2 (ja) 2018-01-31
CL2015001159A1 (es) 2015-08-28
RU2671401C2 (ru) 2018-10-31
MX2015005649A (es) 2015-08-20
ES2587928T3 (es) 2016-10-27

Similar Documents

Publication Publication Date Title
AU2013343685B2 (en) Collagen hydrolyzate and use thereof
JPWO2015083630A1 (ja) コラーゲンペプチド、エラスチンペプチドおよびプロテオグリカンを含む組成物
JP6441825B2 (ja) フィラーの効能維持用組成物
KR102372691B1 (ko) 콜라겐펩티드 함유 조성물의 쓴맛 마스킹 방법
US20130345139A1 (en) Composition for nutrition purposes
CN109965124A (zh) 一种宠物食品及其制备方法
WO2020060761A9 (en) Pet food formulation with cannabinoids
JP4818177B2 (ja) 高齢者向け骨・筋肉増強促進組成物
CN108618997A (zh) 一种用于皮肤护理的含维生素与透明质酸钠的复合物
JP4253296B2 (ja) 健康美容食品
JP6566581B2 (ja) 安定性に優れたセラミド含有組成物
JP2007320891A (ja) 経口用皮膚美容促進組成物
JP2018064494A (ja) グリコサミノグリカンおよびシアル酸含有食品
RU2552444C1 (ru) Композиция продукта с биологически активными свойствами
Beasley et al. The Use of Egg and Egg Compounds in Companion Animal Health
DE202015101782U1 (de) Synergistische Kollagenhydrolysat-Zusammensetzung
WO2025084391A1 (ja) β－ＮＭＮ及びプロテオグリカン含有経口用組成物
JP2017048151A (ja) コラーゲンゲル収縮促進剤、抗糖化剤及び皮膚外用剤
SK500942023U1 (sk) Tyčinka obsahujúca proteíny a hydrolyzovaný kolagén
JP2021185745A (ja) 食品組成物及び食品
CZ8161U1 (cs) Dietetický přípravek obsahující hydrolyzovanou želatinu podílející se na výstavbě pojivových tkání
Zynudheen et al. Fishaceuticals-a detailed investigation
JP2020110066A (ja) コンドロイチン硫酸含有ブタ軟骨抽出物を有効成分とする血圧上昇抑制剤およびそれを含有する食品組成物

Legal Events

Date Code Title Description
TH Corrigenda

Free format text: IN VOL 29 , NO 19 , PAGE(S) 2857 UNDER THE HEADING PCT APPLICATIONS THAT HAVE ENTERED THE NATIONAL PHASE - NAME INDEX UNDER THE NAME GELITA AG, APPLICATION NO. 2013343685, UNDER INID (71) CORRECT THE APPLICANT NAME TO GELITA AG

FGA Letters patent sealed or granted (standard patent)